# EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

> **NCT04189835** · — · COMPLETED · sponsor: **University of Aarhus** · enrollment: 509 (actual)

## Conditions studied

- EBV Infection
- EBV Viremia
- Epstein-Barr Virus Associated Lymphoproliferative Disorder
- Post-transplant Lymphoproliferative Disorder

## Interventions

- **DIAGNOSTIC_TEST:** EBV DNA in whole blood and plasma

## Key facts

- **NCT ID:** NCT04189835
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-03
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04189835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04189835, "EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04189835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*